Effect of Deferoxamine on Post-Transfusion Iron, Inflammation, and In Vitro Microbial Growth in a Canine Hemorrhagic Shock Model: A Randomized Controlled Blinded Pilot Study
Authors:
- Melissa A. ClausMCMelissa A. Claus
- Lisa SmartLSLisa Smart
- Anthea L. RaisisARAnthea L. Raisis
- Claire R. SharpClaire R. Sharp
- Sam AbrahamSASam Abraham
- Joel P. A. GummerJGJoel P. A. Gummer
- Martin K. MeadMMMartin K. Mead
- Damian L. BradleyDBDamian L. Bradley
- Rachel Van SwelmRSRachel Van Swelm
- Erwin T. G. WiegerinckEWErwin T. G. Wiegerinck
- Edward LittonELEdward Litton
Open Access
- 5 February 2023
- journal article
- research article
- Published by MDPI AG in Veterinary Sciences
- Vol. 10 (2) , 121
Abstract
Red blood cell (RBC) transfusion is associated with recipient inflammation and infection, which may be triggered by excessive circulating iron. Iron chelation following transfusion may reduce these risks. The aim of this study was to evaluate the effect of deferoxamine on circulating iron and inflammation biomarkers over time and in vitro growth of Escherichia coli (E. coli) following RBC transfusion in dogs with atraumatic hemorrhage. Anesthetized dogs were subject to atraumatic hemorrhage and transfusion of RBCs, then randomized to receive either deferoxamine or saline placebo of equivalent volume (n = 10 per group) in a blinded fashion. Blood was sampled before hemorrhage and then 2, 4, and 6 h later. Following hemorrhage and RBC transfusion, free iron increased in all dogs over time (both p < 0.001). Inflammation biomarkers interleukin-6 (IL6), CXC motif chemokine-8 (CXCL8), interleukin-10 (IL10), and keratinocyte-derived chemokine (KC) increased in all dogs over time (all p < 0.001). Logarithmic growth of E. coli clones within blood collected 6 h post-transfusion was not different between groups. Only total iron-binding capacity was different between groups over time, being significantly increased in the deferoxamine group at 2 and 4 h post-transfusion (both p < 0.001). In summary, while free iron and inflammation biomarkers increased post-RBC transfusion, deferoxamine administration did not impact circulating free iron, inflammation biomarkers, or in vitro growth of E. coli when compared with placebo.Keywords
Funding Information
- American College of Veterinary Emergency and Critical Care (AC019)
- Murdoch University Veterinary Life Sciences Small Grant (AC019)
- Intensive Care Foundation of Australia and New Zealand (Trainee Grant) (AC019)
- National Collaborative Research Infrastructure Strategy (AC019)
- Murdoch University Research Training Program Scholarship (AC019)
This publication has 60 references indexed in Scilit:
- Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non–transferrin-bound ironBlood, 2011
- HowStaphylococcus aureusAdapts to Its HostNew England Journal of Medicine, 2011
- Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammationBlood, 2010
- Association between length of storage of red blood cell units and outcome of critically ill children: a prospective observational studyCritical Care, 2010
- Duration of red blood cell storage and outcomes in pediatric cardiac surgery: an association found for pump prime bloodCritical Care, 2009
- Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesBMC Medical Genomics, 2009
- Evolution of adverse changes in stored RBCsProceedings of the National Academy of Sciences, 2007
- LPI-labile plasma iron in iron overloadBest Practice & Research Clinical Haematology, 2005
- The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*Critical Care Medicine, 2004
- Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxidesFEBS Letters, 1986